KETAMINE HYDROCHLORIDE INJECTION

Cardinal Health, Inc. (CAGE 00E55) was awarded a delivery order under the indefinite-delivery, indefinite-quantity contract SPE2DX25D8022 for the supply of KETAMINE HYDROCHLORIDE INJECTION, with a total contract value of $443.63. This delivery order, identified as SPE2D926F7848, was awarded on August 2, 2026, and specifies a single line item of 11.000 packages at a unit price of $40.33, delivered FOB destination to the USS CARL M. LEVIN (DDG 120) at FPO AP 96692–1100. The procurement is executed under FAR Part 12 as a commercial item acquisition, incorporating standard clauses 52.212-1, 52.212-3, and 52.212-4, and is rated under the Defense Priorities and Allocations System (DPAS) to ensure priority processing. The awardee certifies as both a Small Business and a Service-Disabled Veteran-Owned Small Business, subject to compliance with corresponding reporting obligations under FAR 52.219-28 and DSBS/FPDS requirements. Delivery must conform to DLAD PROC NOTE C19/C20, with inspection and acceptance performed by the Government at the destination, and items must be properly marked with CLIN, P/N, NDC, manufacturer CAGE codes, TCN, RDD, and S/R voucher information to enable traceability. Packaging and preservation details are not specified beyond adherence to FLEET MILSTRIP logistics standards implied by documentation references, and invoicing is expected via EDI with payment processed under Fast Pay Net 15 terms. The contract does not include option quantities, special performance requirements, or designated COR/COTR/PCO personnel, and while accounting data references a local code BX:97X4930 SCBX0012620S33189, no formal TAS, AAC, or ACRN lines are provided. The parent contract has a $20 million ceiling but this order's value is fixed at $443.63 with no further expansion permitted.